14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $40.39 $44.07 Friday, 3rd May 2024 IONS stock ended at $41.97. This is 2.60% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $41.93 to a day high of $43.76.
90 days $40.39 $51.98
52 weeks $34.79 $54.44

Historical Ionis Pharmaceuticals prices

Date Open High Low Close Volume
Mar 14, 2016 $39.09 $40.86 $38.72 $40.34 1 458 600
Mar 11, 2016 $37.41 $39.45 $37.05 $39.07 1 140 200
Mar 10, 2016 $38.57 $39.34 $35.75 $37.08 1 463 400
Mar 09, 2016 $40.09 $40.09 $37.32 $38.00 1 597 200
Mar 08, 2016 $41.61 $41.86 $38.85 $39.29 1 476 300
Mar 07, 2016 $39.74 $43.00 $39.37 $41.49 1 402 000
Mar 04, 2016 $37.74 $40.63 $37.74 $39.81 1 991 000
Mar 03, 2016 $37.93 $38.90 $37.48 $38.41 1 695 200
Mar 02, 2016 $35.66 $39.17 $35.66 $37.75 2 028 400
Mar 01, 2016 $34.55 $35.96 $33.74 $35.93 1 710 800
Feb 29, 2016 $33.56 $36.48 $33.56 $34.56 1 718 100
Feb 26, 2016 $34.00 $34.28 $31.95 $33.50 1 981 500
Feb 25, 2016 $35.00 $36.84 $32.74 $33.57 2 495 900
Feb 24, 2016 $34.41 $35.40 $32.32 $35.13 3 885 800
Feb 23, 2016 $36.64 $37.10 $34.77 $34.85 1 311 700
Feb 22, 2016 $37.74 $38.40 $36.30 $36.80 1 199 900
Feb 19, 2016 $36.93 $37.28 $35.57 $37.00 1 274 300
Feb 18, 2016 $39.39 $39.50 $36.65 $36.99 1 670 500
Feb 17, 2016 $36.25 $39.32 $36.20 $38.74 2 252 000
Feb 16, 2016 $36.63 $38.10 $35.68 $36.04 1 903 100
Feb 12, 2016 $34.86 $35.84 $33.24 $35.74 2 796 400
Feb 11, 2016 $32.40 $35.25 $30.93 $34.25 2 885 200
Feb 10, 2016 $33.42 $35.40 $32.92 $33.03 1 528 900
Feb 09, 2016 $32.35 $34.82 $31.66 $33.17 2 363 100
Feb 08, 2016 $34.47 $34.69 $31.84 $32.85 1 897 300
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT